Health Condition 1: M791- Myalgia
Conditions
Interventions
Intervention1: Trigger point injection with magnesium and ropivacaine: 1ml injectate of 250 mg magnesium sulphate (500mg/ml) and 0.25% ropivacaine will be injected in the trigger point of neck muscle
Sponsors
Department of Anaesthesiology Pain Medicine and Critical Care AIIMS New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Neck pain more than 3 months 2.Age more than 18years 3.Definitive diagnosis of myofascial pain syndrome of neck muscles with identification of trigger points defined by presence of one or more taut bands in muscle, focal tenderness within these taut bands, local or referred pain on palpation or gentle snapping palpation elicits a twitch response.
Exclusion criteria
Exclusion criteria: 1.Patients not giving consent 2.Any painful conditions of neck and back muscles other than myofascial pain syndrome like fibromyalgia, spondylosis, cervical radiculopathy, vertrebrobasilar insufficiency 3.Known allergy to local anaesthetics or magnesium sulphate 4.History of prior invasive procedure in neck muscle
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numeric Rating Scale for painTimepoint: 3months | — |
Secondary
| Measure | Time frame |
|---|---|
| Numerical Rating Scale for painTimepoint: 14days and 1month;Neck movement using goniometerTimepoint: 1month and 3 months;Pain pressure threshold using algometerTimepoint: 1month and 3months;Neck disability indexTimepoint: 1month and 3 months;Patient satisfaction scoreTimepoint: 1month and 3 months | — |
Countries
India
Contacts
Public ContactDr Dhruv Jain
AIIMS, New Delhi
Outcome results
None listed